Absci Corp. (ABSI)
8.80
-0.04
(-0.45%)
USD |
NASDAQ |
Sep 02, 16:00
8.89
+0.09
(+1.02%)
After-Hours: 20:00
Absci Research and Development Expense (Annual) : 80.72M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 80.72M |
| December 31, 2024 | 63.86M |
| December 31, 2023 | 47.57M |
| December 31, 2022 | 58.91M |
| Date | Value |
|---|---|
| December 31, 2021 | 44.59M |
| December 31, 2020 | 11.45M |
| December 31, 2019 | 4.311M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Twist Bioscience Corp. | 80.28M |
| Prime Medicine, Inc. | 160.64M |
| Beam Therapeutics, Inc. | 409.62M |
| Tenax Therapeutics, Inc. | 32.67M |
| Manhattan Scientifics, Inc. | -- |